Terminated PHASE1 INTERVENTIONAL NCT00000276

Dopamine Reuptake Inhibitors of Cocaine Abuse - 1

Dopamine Reuptake Inhibitors of Cocaine Abuse

Sponsor: National Institute on Drug Abuse (NIDA)

Interventions Bupropion

Updated 6 times since 2017 Last updated: Jun 17, 2020 Started: Sep 30, 1994 Primary completion: Aug 31, 1999 Completion: Aug 31, 1999

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from National Institute on Drug Abuse (NIDA)

See all terminations from National Institute on Drug Abuse (NIDA)

Other Cocaine-Related Disorders trials with similar outcome

Browse all Cocaine-Related Disorders trials

This PHASE1 trial investigates Cocaine-Related Disorders and is currently terminated or withdrawn. National Institute on Drug Abuse (NIDA) leads this study, which shows 6 recorded versions since 1994 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1
Jul 2020 — Jan 2021 [monthly]

Terminated PHASE1
Jun 2018 — Jul 2020 [monthly]

Terminated PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated PHASE1

First recorded

Sep 1994

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
VA Connecticut Healthcare System
Yale University

Data source: Yale University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New Haven, United States